How should topical non‑steroidal anti‑inflammatory eye drops be used for pain relief in a corneal abrasion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Topical NSAIDs for Corneal Abrasion Pain Relief

Topical NSAIDs should be used for pain control in corneal abrasions, but they are NOT a substitute for prophylactic antibiotics, which remain the primary treatment to prevent bacterial keratitis.

Primary Treatment: Antibiotics First

The most critical intervention for corneal abrasions is prophylactic topical antibiotics, particularly in high-risk scenarios 1, 2, 1:

  • Contact lens wearers with corneal abrasion: Topical antibiotics are mandatory to prevent acute bacterial keratitis
  • Traumatic abrasions: Broad-spectrum topical antibiotic recommended for any trauma-related abrasion
  • Timing matters: Treatment should start within 24 hours of the abrasion to prevent ulceration 1

Critical caveat: Do NOT patch the eye in contact lens wearers or use therapeutic contact lenses early on—both increase the risk of secondary bacterial keratitis 2, 1.

Adjunctive Pain Management: Topical NSAIDs

For pain relief specifically, topical NSAIDs are effective and safe 3, 4:

  • Pain reduction: Topical NSAIDs significantly reduce pain scores at 24 hours (standardized mean difference -0.69) and 48 hours (SMD -0.56) 3
  • Reduced oral analgesic use: 53% lower need for oral pain medications compared to control 3
  • Safety profile: No significant delays in healing or increased complications in simple, uncomplicated corneal abrasions 3, 4

Specific NSAID Options

Evidence supports several topical NSAIDs 3, 5, 6:

  • Diclofenac 0.1%: Demonstrated significant pain improvement (2.1-point reduction on 10-point scale at 2 hours) 5
  • Flurbiprofen 0.03%: Significantly lower pain scores over 24 hours 6
  • Ketorolac 0.5%: Included in systematic reviews showing efficacy 3

Dosing approach: Typically prescribed for 24-48 hours (the period of maximal pain), not extended use.

Alternative Pain Management (Less Effective)

Cycloplegics are often overlooked but serve a dual purpose 2:

  • Primary indication: Substantial anterior chamber inflammation (not routine abrasions)
  • Benefits: May decrease pain AND prevent synechia formation
  • Not first-line for pain alone: Evidence for pain control in simple abrasions is insufficient 3

Topical anesthetics for outpatient use: Current evidence does NOT support this practice 7:

  • Insufficient evidence for efficacy in reducing pain at 24-72 hours
  • Concerns about epithelial toxicity and potential for abuse
  • Should remain limited to in-office examination only

Clinical Algorithm

  1. Immediate assessment: Confirm simple corneal abrasion (no penetrating injury, no infection)

  2. Primary treatment (infection prevention):

    • Prescribe broad-spectrum topical antibiotic (e.g., fluoroquinolone)
    • Frequency: Typically 4 times daily until healed
    • Duration: Until epithelial defect resolves (usually 24-48 hours)
  3. Pain management (add to antibiotics):

    • First-line: Topical NSAID (e.g., diclofenac 0.1% or ketorolac 0.5%)
    • Frequency: 4 times daily
    • Duration: 24-48 hours (limited course)
    • Second-line: Oral analgesics (acetaminophen, NSAIDs, or opioids if severe)
  4. Consider cycloplegic (e.g., cyclopentolate 1%) ONLY if:

    • Significant photophobia present
    • Evidence of anterior chamber reaction
    • Not routinely needed for simple abrasions
  5. Avoid:

    • Eye patching (especially in contact lens wearers)
    • Early bandage contact lens use
    • Outpatient topical anesthetics

Important Safety Considerations

Topical NSAIDs are safe for short-term use in simple corneal abrasions 3, 4:

  • No evidence of delayed healing when used appropriately
  • Complications are rare (similar to control groups)
  • Cost is higher than oral analgesics, but patient satisfaction may justify use

However, topical corticosteroids should be AVOIDED in acute corneal abrasions 2:

  • May be considered only after 48 hours when infection is controlled and organism identified
  • Absolutely contraindicated if Acanthamoeba, Nocardia, or fungal infection suspected
  • Not indicated for routine traumatic abrasions

Follow-up

  • Recheck within 24-48 hours to confirm healing
  • Red flags requiring immediate ophthalmology referral: worsening pain, decreased vision, purulent discharge, corneal infiltrate, or no improvement by 48 hours
  • Most simple abrasions heal within 24-48 hours with appropriate treatment 4, 8

Bottom line: Topical NSAIDs are an effective adjunct for pain control in corneal abrasions, but prophylactic antibiotics remain the cornerstone of treatment to prevent sight-threatening bacterial keratitis, particularly in contact lens wearers and trauma cases.

References

Research

Topical pain control for corneal abrasions: A systematic review and meta-analysis.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2021

Research

Topical analgesia for superficial corneal injuries.

Journal of accident & emergency medicine, 1996

Research

Topical ophthalmic anesthetics for corneal abrasions.

The Cochrane database of systematic reviews, 2023

Research

Antibiotic prophylaxis for corneal abrasion.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.